insights_auto
Why is AGIO down ४.०३%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ २७.६०
arrow_downward
-४.०३%(-१.१६) 1D
US$ २७.६०
०.००% (०.००)
bedtimeAfter hours
Closed: नोभेम्बर २०, १६:००:०० GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$ २८.०१
High
US$ २९.१४
Low
US$ २७.४३
Mkt. cap
१.६५ अरब
Avg. vol.
११.२८ लाख
Volume
७.७६ लाख
52-wk high
US$ ४४.०७
52-wk low
US$ २३.०२
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
Open
US$ २८.०१
High
US$ २९.१४
Low
US$ २७.४३
Mkt. cap
१.६५ अरब
Avg. vol.
११.२८ लाख
Volume
७.७६ लाख
52-wk high
US$ ४४.०७
52-wk low
US$ २३.०२
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
News stories
From web sources and news partners
TradingView
·
१ घण्टा पहिले
Ed Yardeni Says Investors Are Overreacting to S&P 500 Selloff
Yahoo Finance
·
४ घण्टा पहिले
In the Last Tech Bust, the S&P 500 Lost Money for a Decade. History Says Stocks With the Highest Yields Gained 5.4% a Year.
Nacionale
·
६ घण्टा पहिले
Is the S&P 500 in a bear market, and will it rally? No, it's in a correction, 11.6% below its record
Beinsure
·
९ घण्टा पहिले
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc